Leading 25 corporate institutions

The leading 25 corporate institutions in health sciences ranked by their article Share (Share) in the subject from 2022 to 2023*. Also listed are each institution's total health sciences article count (Count) from 2022 to 2023* and the subject Share in relation to its overall Share (Subject contribution %).

Click on column headers to sort

Rank	Institution	Location	Share 2022–23*	Count 2022–23*	Subject contribution (%)
1	F. Hoffmann-La Roche AG	Switzerland	33.63	117	35.7%
2	AstraZeneca plc	United Kingdom (UK)	32.90	141	51.1%
3	Pfizer Inc.	United States of America (USA)	28.93	95	55.9%
4	Eli Lilly and Company	United States of America (USA)	28.84	74	76.9%
5	Johnson & Johnson	United States of America (USA)	22.71	94	60.0%
6	Formosa Plastics Group	Taiwan	20.04	55	63.0%
7	Novartis International AG	Switzerland	18.11	91	40.4%
8	GlaxoSmithKline plc. (GSK)	United Kingdom (UK)	16.68	64	54.4%
9	Merck & Co., Inc.	United States of America (USA)	16.42	71	27.2%
10	Sanofi	France	13.66	57	54.3%
11	Regeneron Pharmaceuticals, Inc.	United States of America (USA)	13.37	41	46.5%
12	AbbVie Inc.	United States of America (USA)	12.47	37	50.5%
13	Bristol-Myers Squibb (BMS)	United States of America (USA)	11.60	55	47.2%
14	Novo Nordisk A/S	Denmark	9.94	44	67.4%
15	Samsung Group	South Korea	9.57	108	27.4%
16	Gilead Sciences, Inc.	United States of America (USA)	9.56	40	78.1%
17	Amgen Inc.	United States of America (USA)	8.96	55	45.4%
18	Takeda Pharmaceutical Company Limited	Japan	7.76	19	75.7%
19	Bayer AG	Germany	7.39	47	64.6%
20	Moderna, Inc.	United States of America (USA)	6.66	16	53.2%
21	Techint Group	Italy	5.71	80	74.4%
22	Alphabet Inc.	United States of America (USA)	5.53	16	11.4%
23	Biogen Inc.	United States of America (USA)	5.52	22	60.9%
24	C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim)	Germany	5.19	36	41.4%
25	IVIRMA Global	Spain	5.16	16	100.0%

Footnote

* Data for 2023 represents the period January–July 2023